Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 4, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

August 30, 2025

Conditions
HypoproteinemiaPharmacokineticsCiprofol
Interventions
DRUG

ciprofol

Patients who intended to undergo elective surgery under general anesthesia were induced by a single intravenous injection of 0.3mg/kg and ciprofol, and the experimental drug was manually injected by CVC within 30s. 2ml of venous blood was collected before and after administration 0.5min, 1min, 2min, 3min, 5min, 8min, 15min 30min, 1h, 2h and 4h respectively. The concentration of cyclopofol in blood was measured

Trial Locations (1)

310000

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
lead

Xie Kangjie

OTHER

NCT06425757 - Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia | Biotech Hunter | Biotech Hunter